Eleven Biotherapeutics Inc (NASDAQ:EBIO)

8.77
Delayed Data
As of 4:00pm ET
 -0.15 / -1.68%
Today’s Change
8.65
Today|||52-Week Range
17.48
-26.18%
Year-to-Date

Today’s Trading

Previous close8.92
Today’s open8.94
Day’s range8.65 - 9.08
Volume22,165
Average volume (3 months)45,131
Market cap$161.5M
Dividend yield--
Data as of 4:00pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)-66.90%
Earnings growth (this year)+18.23%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+68.14%
P/E ratioNM
Price/Sales77.56
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SYNSynthetic Biologics ...-0.03-1.37%
GLYCGlycoMimetics Inc-0.18-2.16%
SNSSSunesis Pharmaceutic...+0.05+2.04%
MDWDMediwound Ltd-0.13-1.80%
Data as of 4:00pm ET, 04/01/2015

Financials

Next reporting dateMay 14, 2015
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$2.2M
Annual profit (last year)-$34.2M
Net profit margin-1,522.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Abbie C. Celniker
Chief Financial &
Business Officer
Gregory D. Perry
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account